Navigating an uncertain regulatory environment for mRNA-based products
本篇文章概述了在不确定的监管环境中应对基于mRNA的产品的优秀实践，并探讨了为什么与CDMO合作可以让生物技术和制药公司遵守监管准则，有备无患。
Added Date:
2024-04-23Filters:
| Filter Category | Filter Values |
|---|---|
| Month |
|
| Capability |
|
| Year |
|
| Language |
|
| Asset Type |
|
| Country |
|
| Region |
|
| Market Category |
|
Country Availability:
()